Abstract:Purpose: In order to build up a reliable dose monitoring system for boron neutron capture therapy (BNCT) applications at the TRIGA reactor in Mainz, a computer model for the entire reactor was established, simulating the radiation field by means of the Monte Carlo method. The impact of different source definition techniques was compared and the model was validated by experimental fluence and dose determinations. Methods: The depletion calculation code origen2 was used to compute the burn-up and relevant material composition of each burned fuel element from the day of first reactor operation to its current core. The material composition of the current core was used in a mcnp5 model of the initial core developed earlier. To perform calculations for the region outside the reactor core, the model was expanded to include the thermal column and compared with the previously established attila model. Subsequently, the computational model is simplified in order to reduce the calculation time. Both simulation models are validated by experiments with different setups using alanine dosimetry and gold activation measurements with two different types of phantoms. Results: The mcnp5 simulated neutron spectrum and source strength are found to be in good agreement with the previous attila model whereas the photon production is much lower. Both mcnp5 simulation models predict all experimental dose values with an accuracy of about 5%. The simulations reveal that a Teflon environment favorably reduces the gamma dose component as compared to a polymethyl methacrylate phantom. Conclusions: A computer model for BNCT dosimetry was established, allowing the prediction of dosimetric quantities without further calibration and within a reasonable computation time for clinical applications. The good agreement between the mcnp5 simulations and experiments demonstrates that the attila model overestimates the gamma dose contribution. The detailed model can be used for the planning of structural modifications in the thermal column irradiation channel or the use of different irradiation sites than the thermal column, e.g., the beam tubes.

Dependence of neutron rate production with accelerator beam profile and energy range in an ADS-TRIGA RC1 reactor

Study on Production Method of the {sup 178m2}hf Isomer for Induced Gamma Emission

Production Cross Sections of 102mrh and 108mag in Proton Bombed Natpb Target with 400 MeV Energy

Neutron radiation characteristics of the IVth generation reactor spent fuel

Evaluation of Nuclear Activation of Tungsten Plates for Future Modeling of a Medical Accelerator

Influence of Particle Beam and Accelerator Type on ADS Efficiency

Research On Nuclear Heat Deposition Behavior In The Spallation Target Of An Accelerator Driven Subcritical System

Confirmation of a realistic reactor model for BNCT dosimetry at the TRIGA Mainz

A new method in the production of Ac-227, Ra-228, Th-228 and U-232 on Thorium target from different perspective for use in Radioisotope Power Systems and Nuclear Batteries

Effect of High-Energy Neutron Source on Predicting the Proton Beam Current in the ADS Design

Modeling To Characterize Neutron Activation Products In A Medical Linear Accelerator

Study of External Source Effects for Different Multibeam Concept for Accelerator-Driven Subcritical Reactor for Nuclear Waste Transmutation (ADS-NWT)

Developing a new target design for producing 99Mo in a MTR reactor

Productions of high energy neutrons by interactions between deuteron beam and thick target

The Properties Study on Solid Metal Neutron Production Target Proton-Induced with Energy of 150 MeV for an ADS Verification Facility

Investigation of target in C-ADS and IAEA ADS benchmark

Problem of the spallation neutron production source related to accelerator-driven systems

Study of Properties of the Neutron Production Target Induced from 150-Mev Incident Proton Energy for the China Ads

Radiation transport calculations for the European Spallation Source accelerator environment

Neutron Yield of Thermo Scientific P385 D-T Neutron Generator vs. Current and Voltage

SU-FF-T-296: Modeling to Characterize Neutron Activation Products in a Medical Linear Accelerator